Cyfendus Anthrax Vaccine Wins FDA Approval
XTalks
JULY 25, 2023
Anthrax is a rare, yet severe disease caused by the bacterium B. Cyfendus functions by stimulating the production of antibodies targeted against the protective antigen protein. These antibodies play a crucial role in providing protection by effectively neutralizing the cytotoxic lethal toxin and edema toxin of B.
Let's personalize your content